Last reviewed · How we verify
Single administration Amg dose Group — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Single administration Amg dose Group (Single administration Amg dose Group) — J2H Biotech.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Single administration Amg dose Group TARGET | Single administration Amg dose Group | J2H Biotech | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Single administration Amg dose Group CI watch — RSS
- Single administration Amg dose Group CI watch — Atom
- Single administration Amg dose Group CI watch — JSON
- Single administration Amg dose Group alone — RSS
Cite this brief
Drug Landscape (2026). Single administration Amg dose Group — Competitive Intelligence Brief. https://druglandscape.com/ci/single-administration-amg-dose-group. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing